Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA ® 800 mg ( " Jonson & Jonson " , Russia)
Condition: Bioequivalence Interventions: Drug: GP30101; Drug: Prezista® Sponsor: Geropharm Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2020 Category: Research Source Type: clinical trials
